Feedback / Questions
Kardorisso (asandeutertinib) - TYK Medicines
https://www.tykmedicines.com/en/newes/tyk-medicines-inc-s-egfr-targeted-innovative-drug-asandeutertinib-demonstrates-excellent-efficacy-in-nsclc-patients-with-brain-metastases-interim-results-from-the-esaona-pivotal-st/
Aug 14, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next